About
Vison
To lead the evolution of medical imaging through our AI-driven technology, envisioning a future where real-time conversion of 2D medical scans into precise, interactive 3D models enhances diagnostics, treatment planning, and therapeutic outcomes, ultimately revolutionizing healthcare.
Mission
Our mission is to pioneer advanced AI solutions that rapidly transform 2D medical images into accurate 3D representations, facilitating quicker and more comprehensive insights for healthcare professionals. Committed to improving patient care, we strive to provide accessible, high-fidelity 3D medical imaging system, augmenting diagnostics, treatment decisions, and surgical interventions in real time.
History
About Company
NOVIUS Corporation registered capital of 20 million yen
Started development of signage and beacon linked application
02
Received an order from a major fruit and vegetable company to develop a prototype of the above 03
Installed face recognition signage for a major chain company and acquired know-how of signage advertising. 04
Started to develop age authentication system. 05
Installed face recognition signage for a major chain company and acquired know-how of signage advertising. 06
Delivered one unit of face recognition signage to a major parts manufacturer. 07
Started developing real-time style transfer technology to convert live video to effected.08
Concluded a technical partnership agreement with THINKPALM (Headquartered in India) 09
Obtained patent for real-time style transfer . Patent number: 6529102 10
Received Entrepreneurship Award from Asia-Japan Federation of Excellent Companies11
NVIDIA Inception partner Certification 12
We successed development of real-time security system by using AI 13
We successed development of Glassless 3D Technology Using AI-Technology From 2D To 3D Image Conversion In Real-Time 13
Adopted By Microsoft For Startups 14
Certified Intel® Alliance Partner 15
AI Generated Advanced Research & Development NCC (National Cancer Center) Concluded Joint Research, And Development Agreement With NOVIUS 16
We Selected As One Of The 10 Finalists For The 31st General Assembly Of The Japanese Association Of Medical Sciences Exposition X CIC. 17
We Start AGI (Artificial General Intelligence) Research and Development This Year. 18
We’re Able To Obtain An NCAGE CODE Number. 19
We’re Able To Obtain An Unique Entity Identifier. 20
Incorporated “NOVIUS Company,” A Local Subsidiary In Delaware, U.S.A. 22
